DNA Vaccine Innovation May Shift Treatment Paradigm for Patients Living with Recurrent Respiratory Papillomatosis
Dr. Jeff Skolnik, Senior Vice President of Clinical Development at INOVIO Pharmaceuticals, discusses the current research and development of a DNA vaccine for recurrent respiratory papillomatosis (RRP), a rare disease caused by HPV types 6 and 11. He also talks about other DNA-based medicines INOVIO is developing to treat cancers and infectious diseases.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Jeffrey Skolnik, M.D.
Senior Vice President, Clinical Development
Dr. Skolnik leads INOVIO’s HPV and immuno-oncology DNA medicines teams. He is a key member of the leadership team overseeing global clinical assets for DNA medicines aimed to treat HPV-related disease and cancers.
Dr. Skolnik was previously at Tetralogic Pharmaceuticals, where he was Vice President of Clinical Research and later Chief Medical Officer, and oversaw all clinical programs in oncology, infectious diseases and dermatology. He has held several leadership positions in Clinical Development and Medical Affairs for AstraZeneca and GSK, for both early and late-stage compounds. Dr. Skolnik received his M.D. degree with honors from New York University and received his pediatric training at Children’s Hospital, Boston and completed his hematology/oncology training at The Children’s Hospital of Philadelphia, where he continues on staff as an Attending Physician.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
